Navigation Links
Medicis in Medical News

BioMarin Announces Second Quarter 2009 Financial Results

... June 30, 2009, BioMarin had cash and short and long-term investments totaling $485.3 million. During the quarter, BioMarin made the final payment to medicis of $70.6 million related to the Orapred transaction. "During the quarter, we reported encouraging results from the Phase I PEG-PAL study, initi...

Dr. John L. LeRoy First Atlanta Plastic Surgeon to Perform Newly Approved Dysport Wrinkle Remover Injections for Facial Rejuvenation

... to use it. Dr. John L. LeRoy is helping Atlanta-area patients reduce the appearance of fine lines and wrinkles with the new Dysport®, licensed by medicis from French developer Ipsen. Dysport® functions much the same way as BOTOX® injections, and may now be considered one of its main competitors....

The Secrets to Staying Beautiful; Making the Most of Your Beauty Budget

...ylane ((R)) [Instructions for Use] Scottsdale, AZ: medicis Pharmaceutical Corporation; December 2008. ...rlane ((R)) [Instructions for Use] Scottsdale, AZ: medicis Pharmaceutical Corporation; February 2009. ...marks of HA North American Sales AB. (C) 2009 medicis Aesthetics Inc. RES 09-038A 06-30-10 ...

The Secrets to Staying Beautiful; Making the Most of Your Beauty Budget

...ylane ((R)) [Instructions for Use] Scottsdale, AZ: medicis Pharmaceutical Corporation; December 2008. ...rlane ((R)) [Instructions for Use] Scottsdale, AZ: medicis Pharmaceutical Corporation; February 2009. ...marks of HA North American Sales AB. (C) 2009 medicis Aesthetics Inc. RES 09-038A 06-30-10 ...

New Survey Reveals High Expectations for Popular Aesthetic Injections

...linum Toxin Survey NewsWorthy Analysis. February--March 2009. Data on file, medicis Pharmaceutical Corporation. 2. Kelton Research. Botulinum Toxin Survey Topline Report. February--March 2009. Data on file, medicis Pharmaceutical Corporation. Important Safety Information Dysport...

Coapt Systems, Inc. Launches Hydrelle(TM) a New, FDA-Approved Dermal Filler with Lidocaine for Significant Wrinkle Correction and Greater Patient Comfort

...d effective, Hydrelle is also a financially attractive alternative to traditional fillers such as Juvederm(R) by Allergan Medical, and Restylane(R) by medicis Pharmaceutical. Hydrelle has been specifically formulated to deliver rapid results comparable to other hyaluronic acid fillers; and the lidocaine...

Hyperion Therapeutics Raises $60 Million Series C

...ent of therapies that address critical unmet needs in the areas of gastroenterology and hepatology. Hyperion and Ucyclyd Pharma, Inc., a subsidiary of medicis Pharmaceutical Corporation, entered into a collaboration agreement for HPN-100 in August 2007. Under the terms of the agreement, Hyperion is conductin...

Joseph E. Whitters Joins MyoScience, Inc. Board of Directors

...ns in aesthetics. Major investors in MyoScience, include De Novo Ventures, Accuitive Medical Ventures, Nexus Medical Partners, Saratoga Ventures, and medicis Capital GmbH. Press Contacts: Robert M. Curtis, President and CEO MyoScience, Inc. bcurtis@myoscience.com (650) 474-2600...

Hyperion Therapeutics Announces Results of Phase I Study in Patients With Liver Cirrhosis

...ent of therapies that address critical unmet needs in the areas of gastroenterology and hepatology. Hyperion and Ucyclyd Pharma, Inc., a subsidiary of medicis Pharmaceutical Corporation, entered into a collaboration agreement for HPN-100 in August 2007. Under the terms of the agreement, Hyperion is conductin...

New Botox(R) Alternative Dysport(TM) FDA Approved, Ready to Rumble

...omote the Dysport(TM) brand as part of a U.S. sales agreement with the manufacturer, Ipsen. Adding Dysport(TM) to their dermal filler empire positions medicis as a formidable foe to Allergan and their arsenal of beauty treatments (Botox(R) and the Juvederm(R) hyaluronic acid gel fillers). Botox(R) by Al...
Medicis in Medical Technology

Hyperion Therapeutics Receives Orphan Drug Designation for HPN-100 for the Treatment of Urea Cycle Disorders

...al unmet needs and underserved patient populations in the areas of gastroenterology and hepatology. Hyperion and Ucyclyd Pharma, Inc., a subsidiary of medicis Pharmaceutical Corporation, entered into a collaboration agreement for HPN-100 in August 2007. Under the terms of the agreement, Hyperion is conductin...

Hyperion Therapeutics Announces Results for Phase II Study in Urea Cycle Disorders

...enal excretion of phenylacetylglutamine, which is formed from phenylacetic acid and glutamine. Hyperion and Ucyclyd Pharma, Inc., a subsidiary of medicis Pharmaceutical Corporation, entered into a collaboration agreement for HPN-100 in August 2007. Under the terms of the agreement, Hyperion is conducti...

RADIESSE More Effective Than Restylane As Reported In a 60-Patient Clinical Trial

... RADIESSE(R) is a registered trademark of BioForm Medical, Inc. Restylane(R) is a registered trademark of HA North American Sales AB, a subsidiary of medicis Pharmaceutical Corporation. Contact: Adam Gridley 650.286.4025 Vice President, Corporate Development BioForm Medical, Inc. ...
Medicis in Biological Technology

DermAvance Pharmaceuticals Announces Investment by Ben Franklin Technology Partners of Southeastern Pennsylvania

...e soft-tissue volume loss, thus returning the dermis to its original youthful state. Current marketed fillers include market-leader Restylane, sold by medicis Pharmaceutical, and Radiesse sold by Bioform. "We were very pleased to be selected for an investment by Ben Franklin Technology Partners as a part o...

QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes (As Revised)

...SI ) Imclone Systems (Nasdaq: IMCL ) Inverness Medical Innovations (Amex: IMA ) Invitrogen Corp. (Nasdaq: IVGN ) Medarex Inc. (Nasdaq: MEDX ) medicis Pharmaceutical (NYSE: MRX ) Mentor Corp. (NYSE: MNT ) ONYX Pharmaceuticals Inc. (Nasdaq: ONXX ) PDL BioPharma, Inc. (Nasdaq: PDLI ) Pharmion C...

BioMarin Announces Fourth Quarter and Full Year 2007 Financial Results

...demarks of BioMarin Pharmaceutical Inc. Aldurazyme(R) is a registered trademark of BioMarin/Genzyme LLC. Orapred(R) is a registered trademark of medicis Pediatrics, Inc. and is used under license. Contact: Investors Media Eugenia Shen ...

Hyperion Therapeutics, Inc. Announces Senior Management Team and $15M Financing Event

...s commitments and capitalize on the opportunity presented by our recently announced strategic collaboration with Ucyclyd Pharma, Inc., a subsidiary of medicis Pharmaceutical Corporation," said Chris Rivera, President and CEO. "This team brings a unique and proven track record of developing, gaining regulator...

Hyperion Therapeutics Secures $40 Million In Series B Round

...confidence in Hyperion and our team," said Chris Rivera, President and CEO of Hyperion. "The funding will allow us to complete the licensing deal with medicis Pharmaceutical Corporation (see press release dated August 28, 2007), build out our management team, advance our clinical trials in UCD and HE, and be...

BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco

... trademarks of BioMarin Pharmaceutical Inc. Aldurazyme(R) is a registered trademark of BioMarin/Genzyme LLC. Orapred(R) is a registered trademark of medicis Pediatrics, Inc. and is used under license. Contact: Investors Media Eugenia Shen ...
Other Tags
(Date:12/24/2014)... Dr. Svetlana Gomer, MGS Tewksbury Dental, MGE ... with US Marines on November 14, 2014 for the ... Toys for Tots Literacy Program. This year’s event ... and audio books for the Toys for Tots Literacy ... It represents another major strike in the battle being ...
(Date:12/24/2014)... FL (PRWEB) December 24, 2014 There’s a ... days. With the Republican Party now in control of the ... again for the Affordable Care Act. A lawsuit has been ... delays of certain provisions in the ACA have resulted in ... Also, a Supreme Court hearing will take place to weigh ...
(Date:12/24/2014)... (PRWEB) December 24, 2014 Dental implants ... for a tooth replacement. They offer the strongest and ... advantages over other forms of tooth replacement. They will ... on the adjacent teeth for support, and they prevent ... have been told that they are not suitable candidates ...
(Date:12/24/2014)... Las Vegas, NV (PRWEB) December 24, 2014 ... Home Services reminds homeowners that before investing time ... start by consulting a licensed professional that specializes in ... who may plan to replace their water heater in ... making a final decision. , Greenstar Home Services ...
(Date:12/24/2014)... December 24, 2014 In June 2014, ... States rode bicycles, hand cycles and recumbent bicycles nearly ... the inaugural CanAm Veterans’ Challenge . “Capital to ... T.E.A.M. Sports about this inspiring ride, is now available ... 50 full color photographs taken during the two-week ride, ...
Breaking Medicine News(10 mins):Health News:Dr. Svetlana Gomer, MGS Tewksbury Dental and Other Dentists Working With the U.S. Marines Strike Again In the Battle Against Illiteracy 2Health News:Dr. Svetlana Gomer, MGS Tewksbury Dental and Other Dentists Working With the U.S. Marines Strike Again In the Battle Against Illiteracy 3Health News:Steven Gerst MD Discusses How, Amid Political Opposition, Court Challenges, and a New Open Enrollment Period, the Affordable Care Act still Relies on Health Informatics 2Health News:Steven Gerst MD Discusses How, Amid Political Opposition, Court Challenges, and a New Open Enrollment Period, the Affordable Care Act still Relies on Health Informatics 3Health News:Innovative Dental Implant Procedure to Gain Momentum in the New Year 2Health News:Greenstar Home Services Offers Tankless Water Heater Advice to Local Homeowners 2Health News:New Commemorative Book Celebrates CanAm Veterans’ Challenge Bike Ride 2Health News:New Commemorative Book Celebrates CanAm Veterans’ Challenge Bike Ride 3
(Date:12/5/2014)... Dec. 4, 2014  Tute Genomics, a leader in ... in Series A1 funding led by UK-based Eurovestech. Peak ... in the investment round. "We are at ... adopts next-generation sequencing and seeks new approaches for the ... Robison , MD MBA, and CEO of Tute Genomics. ...
(Date:11/21/2014)... DALLAS , November 18, 2014 ... Security Systems Market by Systems (Video, RFID, Access Control, ... (SEZ, Factories, Hotels, Banks, Government), Component Service Geography - ... Security Systems Market is projected to be around $25 ... Billion by 2020, growing at a CAGR of 8.69%. ...
(Date:11/21/2014)... 20, 2014   Atmel® Corporation (NASDAQ: ... and touch technology solutions, today launched the industry,s first ... the widest V cc range from 1.7V to ... faster I 2 C bus communication speeds, and are ... making them ideal for consumer, industrial, computer, and medical ...
Breaking Biology News(10 mins):Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4
Other Contents